I don't get the sense from this comment that you totally know what you're talking about (neither is it my area of expertise). On the one hand, you're right that

I don't get the sense from this comment that you totally know what you're talking about (neither is it my area of expertise). On the one hand, you're right that many humans are actively working on this problem. On the other hand, the data suggests to me that you might be overly optimistic. Only 2 new classes of antibiotics (oxazolidinones and cyclic lipopeptides) have been developed in the last 40 years. The rate of new antibiotic drugs reaching the market has decreased significantly as well. There are a finite number of biological mechanisms for antibiotics to disrupt, and the methods that bacteria use to develop resistance are quite general.